Authors


J. Erika Haydu, MD, PhD

Latest:

Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical Considerations

This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.


Matthew Brown, MS

Latest:

Breaking Silos: How Health Systems and Manufacturers Can Drive Progress Together

Vanderbilt Specialty Pharmacy and Takeda Oncology are reaching across silos and entering an innovative partnership to improve patient care across the entire medication journey.


Anessia Ellerson, BS, CPhT-ADV, CSPT

Latest:

Find New Career Paths and Opportunities for Advancement

My own experience has illustrated how embracing change can lead to growth.


Caitlin Dowd-Green, PharmD, MBA

Latest:

Pharmacists Are Over-Looked Travel Specialists

As the summer months approach, pharmacists can offer many services to ensure patients remain safe and healthy during their travels.


Lauren Dietz, PharmD

Latest:

HOPA 2025: Insights Into Post-Transplant Cyclophosphamide Use for Graft-Versus-Host Disease Prevention

Lauren Dietz, PharmD, highlighted the role of oncology pharmacists in guiding prophylaxis decisions to optimize transplant outcomes.


George Yaghmour, MD

Latest:

USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ Disease

Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.


David White

Latest:

What’s Next in Health Care: How Pharmacies Can Help Serve Their Communities Better

Key trends such as consolidation create an opportunity for independent pharmacies with a community-based approach.


Wiktoria Bogdanska, PharmD, BCOP

Latest:

HER2-Targeted Treatments for NSCLC: Introducing Zongertinib

Currently, standard first-line chemotherapy with or without immunotherapy for patients with non-small-cell lung cancer (NSCLC) with HER2 mutations has limited efficacy.


Nicholas C Smith, Tanae’Ja C Burroughs, Patric H Gaspard, Nandi P Okonkwo, Duy P Tran, Phyllisity V Walters, PharmD Candidates; Jocelyn D. Spates, PharmD, BCPS

Latest:

New Drug Overview: Aducanumab-Avwa (Aduhelm) for Alzheimer Disease

Aducanumab-avwa is a monoclonal antibody that is the first treatment of its class designed to target the amyloid β protein, a biomarker of Alzheimer disease and other dementias.


Kate Starr

Latest:

Industry Trend Report: Consumer Comfort With Pharmacy-Provided Vaccinations and Services Grows

Pharmacies can reach patients who are not receiving vaccines from a pharmacy but are willing to receive them.



Madeline King, PharmD, BCIDP

Latest:

CDC and FDA Recommendations for SARS-CoV-2 Booster Shots

Experts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.


Jazz-Lynn Butler, PharmD, CPh

Latest:

Improving Hypertension Management: Home Blood Pressure Monitoring and Medication Adherence

One of the most important drivers of a patients’ uncontrolled hypertension is medication nonadherence.


Sanskriti Thakur

Latest:

Opinion: Clinical Trials Should Be Accessible to Everybody

A lack of access, awareness, and trust have led to a lack of affordability, effectiveness, and inclusivity.



Alexandra S. Wolff, PharmD, BCOP, FHOPA

Latest:

HOPA Fellow Reflects on Mentorship, Leadership, and the Future of Oncology Pharmacy

Alexandra Wolff, PharmD, BCOP, FHOPA, was awarded a fellow of HOPA at the 2025 annual meeting.


Roger Orr, PharmD, BCOP

Latest:

Outcomes of Pharmacist-Driven Clinical Interventions in a Medically Integrated Oncology Specialty Pharmacy Practice

The high acceptance rates of these interventions demonstrate the key role in optimizing patient care that clinical oncology pharmacists with access to medical records play.


Richie Davis

Latest:

A 340B Compromise at Last? Draft Federal Legislation May Provide a Clear Path Forward

In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.


Sarah Meade

Latest:

Pharmacists Play Pivotal Role in Increasing Awareness of Prediabetes

Answering questions, monitoring, medication therapy, lifestyle modifications help prevent type 2 diabetes.


PTCB Staff

Latest:

The Value of a Pharmacy Technician

Pharmacy Technician Day celebrates the myriad contributions of the unsung heroes of health care.


Dustin Baum, PharmD, BCPS, MHA

Latest:

Elevating Stroke Care: A Pharmacy Perspective on Telestroke Services

In recent years, telestroke services have transformed stroke care delivery, especially in rural or underserved areas.


Prem Shah, PharmD, Executive Vice President of Specialty and Product Innovation, CVS Health

Latest:

How PBMs Can Help Control the Cost of Specialty Medications

PBMs can implement a clinically rigorous approach to specialty pharmacy management that ensures members have appropriate access while helping payers control their pharmacy spend.


Joni Carroll, PharmD, BCACP

Latest:

How to Use Data to Transform Pharmacy Practice

Tips to help community-based pharmacists use the data at their fingertips to better market and provide the enhanced pharmacy services that drive practice transformation.


Katelynn Tran, PharmD, BCPS

Latest:

Clinical Overview of Quizartinib for Acute Myeloid Leukemia

The oral therapy is available through a REMS program.


Siddhi Bagwe-Parab

Latest:

Metal Ion Chelators Hold Enormous Potential in Neurodegenerative Disorders

Monitoring metal ion concentrations and chelation therapy is hypothesized to alleviate symptoms and diseases caused by neuroinflammation.


Steven P. Mathew, PharmD

Latest:

New Migraine Treatments Provide More Options for Easing, Preventing Symptoms

Pharmacists can potentially improve the health and quality of life of millions of people by staying up to date with advancements in migraine treatments.


Haydn Boehm

Latest:

Overcoming the Biotech Investment Paradox

Big pharma companies have become more measured in their risk taking, with mergers and acquisitions gradually giving way to joint ventures and partnerships.


Christina Nault

Latest:

Reexamining the Use of Tacrine for Neurological Diseases

Tacrine was originally brought to the market in 1993 as an acetylcholinesterase inhibitor to fight the symptoms of Alzheimer disease.


Isabella Ruiz-Baker, PharmD Candidate

Latest:

Monkeypox Treatment and Prevention: Stopping the Latest Outbreak

There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.


Katie Cook, PharmD Candidate

Latest:

Addressing COVID-19 Vaccination Hesitation as a Pharmacist

Pharmacists are at the forefront of not only providing COVID-19 vaccinations, but also the information a patient needs before receiving the vaccine